세계의 폐암 수술 장비 시장 보고서(2025년)
Lung Cancer Surgery Equipment Global Market Report 2025
상품코드 : 1769647
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

폐암 수술 장비 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 예상 성장은 비흡연자의 폐암 발병률 증가, 전 세계 인구 고령화, 최소 침습 수술 기법의 확대, 로봇 보조 흉부 수술에 대한 수요 증가, 의료비 지출 증가, 수술 후 회복 결과 개선, 외래 흉부 수술의 급증, 유리한 규제 승인, 폐암 캠페인을 통한 인식 제고, 신흥 시장의 보험 적용 범위 확대 등에 기인할 수 있습니다. 이 기간 동안 예상되는 주요 동향으로는 로봇 보조 수술 플랫폼의 채택, 수술 계획에 AI 적용, 3D 이미징의 수술 절차 통합, 소형 흉강경 기기의 발전, 시각화 기술의 개선, 원격 수술 기능의 성장, 실시간 수술 중 내비게이션, 스마트 스테이플러 및 기기의 활용, 3D 프린팅을 사용한 맞춤형 수술 기기의 개발, 수술 후 모니터링을 위한 AI 기반 시스템의 구현 등이 있습니다.

폐암의 유병률이 증가함에 따라 향후 몇 년 동안 폐암 수술 장비 시장의 성장이 촉진될 것으로 예상됩니다. 폐암은 폐에서 비정상적인 세포가 통제되지 않고 증식하는 질환으로, 흡연이나 유해한 환경 요인에 노출되어 발생합니다. 폐암 발병률의 증가는 주로 전 세계 인구의 고령화와 함께 담배 연기, 대기 오염, 직업적 발암 물질 등 위험 요인에 대한 노출이 증가한 것과 관련이 있습니다. 폐암 수술 장비는 정확한 수술 절차와 효과적인 환자 모니터링을 통해 질병 진단, 암 조직 제거, 수술 후 관리에 중요한 역할을 합니다. 예를 들어, 2025년 2월 호주 기반 비영리 단체인 암 협회(Cancer Council)는 2024년 호주에서 약 1만 5,122명이 폐암 진단을 받았으며, 진단 시 평균 연령은 72세라고 보고했습니다. 폐암은 해당 국가에서 다섯 번째로 많이 진단되는 암이며, 85세까지 호주인 20명 중 1명이 폐암 진단을 받을 것으로 예상됩니다. 따라서 폐암의 증가하는 유병률은 폐암 수술 장비 시장의 확장에 기여하고 있습니다.

폐암 수술 장비 시장의 선도 기업들은 종양 위치 파악 및 생검의 정확성과 안전성을 높이고, 접근이 어려운 폐 결절에 대한 접근을 용이하게 하며, 조기 및 정확한 폐암 진단을 지원하기 위해 로봇 보조 기관지경경화 장치의 개발에 집중하고 있습니다. 로봇 보조 기관지경경화술은 로봇 시스템을 사용하여 기관지경(얇고 유연한 튜브)을 폐로 안내하는 첨단 시술로, 기존의 수동 방식에 비해 정확성과 제어력이 뛰어납니다. 예를 들어, 2025년 3월 미국 제약 회사 존슨 앤 존슨은 자사의 고급 로봇 보조 기관지 내시경 기술인 MONARCH QUEST 시스템이 미국 식품의약국(FDA)으로부터 510(k) 승인을 받았다고 발표했습니다. 이 시스템은 최소 침습적 기술을 통해 폐암 진단을 개선하기 위해 개발된 MONARCH 플랫폼의 차세대 버전입니다. MONARCH QUEST 시스템은 GE HealthCare OEC 3D 모바일 CBCT 이미징 시스템과 통합되어 시술 중 실시간 3D 이미징을 가능하게 합니다. 이 통합을 통해 폐 결절, 특히 접근이 어려운 부위에 위치한 결절의 표적 정확도가 크게 향상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Lung cancer surgery equipment encompasses specialized medical devices and tools utilized during surgical procedures aimed at diagnosing, treating, and monitoring lung cancer. This category includes surgical instruments, imaging devices, biopsy tools, electrosurgical equipment, access devices, and patient monitoring systems, all designed to aid in tumor removal, reduce complications, and support patient recovery.

The primary categories of lung cancer surgery equipment consist of surgical instruments, access devices, imaging systems, electrosurgical tools, biopsy devices, and patient monitoring equipment. Surgical instruments are precision tools employed by surgeons to cut, clamp, grasp, or suture tissue during procedures. Common surgical approaches for lung cancer include lobectomy, pneumonectomy, wedge resection, video-assisted thoracoscopic surgery (VATS), and robotic-assisted surgery. These surgeries serve purposes such as diagnosis, treatment, and post-operative care or rehabilitation. The equipment is used across various end users, including hospitals, surgical clinics, ambulatory surgical centers, and research or academic institutions.

The lung cancer surgery equipment market research report is one of a series of new reports from The Business Research Company that provides lung cancer surgery equipment market statistics, including the lung cancer surgery equipment industry global market size, regional shares, competitors with the lung cancer surgery equipment market share, detailed lung cancer surgery equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the lung cancer surgery equipment industry. This lung cancer surgery equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lung cancer surgery equipment market size has grown strongly in recent years. It will grow from $3.49 billion in 2024 to $3.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be credited to factors such as the increasing prevalence of smoking, improved rates of early diagnosis, better surgical survival outcomes, greater adoption of lobectomy procedures, implementation of government cancer screening initiatives, expansion of hospital infrastructure, availability of skilled thoracic surgeons, a rise in open thoracotomy surgeries, limited surgical alternatives, and reimbursement support for cancer-related surgeries.

The lung cancer surgery equipment market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth during the forecast period can be attributed to the increasing incidence of lung cancer among non-smokers, a globally aging population, the expansion of minimally invasive surgical techniques, rising demand for robotic-assisted thoracic procedures, increased healthcare expenditures, better post-surgical recovery outcomes, a surge in outpatient thoracic operations, favorable regulatory approvals, heightened awareness driven by lung cancer campaigns, and broader insurance coverage in emerging markets. Key trends expected during this period include the adoption of robotic-assisted surgical platforms, application of AI in surgical planning, integration of 3D imaging into surgical procedures, advancement of smaller thoracoscopic instruments, improved visualization technologies, growth in remote surgical capabilities, real-time intraoperative navigation, utilization of smart staplers and instruments, development of personalized surgical tools using 3D printing, and implementation of AI-based systems for post-surgical monitoring.

The increasing prevalence of lung cancer is anticipated to drive the growth of the lung cancer surgery equipment market in the coming years. Lung cancer is a condition characterized by the uncontrolled growth of abnormal cells in the lungs, often caused by smoking or exposure to harmful environmental factors. The rise in lung cancer cases is primarily linked to increased exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens, along with an aging global population. Lung cancer surgery equipment plays a critical role in diagnosing the disease, removing cancerous tissue, and facilitating post-operative care through accurate surgical procedures and effective patient monitoring. For example, in February 2025, the Cancer Council, an Australia-based non-profit organization, reported that an estimated 15,122 individuals were diagnosed with lung cancer in Australia in 2024, with the average age at diagnosis being 72. Lung cancer is the fifth most commonly diagnosed cancer in the country, and around one in 20 Australians is projected to be diagnosed with it by the age of 85. Hence, the rising prevalence of lung cancer is contributing to the expansion of the lung cancer surgery equipment market.

Leading companies in the lung cancer surgery equipment market are concentrating on the development of robotically assisted bronchoscopy devices to enhance the accuracy and safety of tumor localization and biopsy, facilitate access to difficult-to-reach lung nodules, and support early and precise lung cancer diagnosis. Robotically assisted bronchoscopy is an advanced procedure that employs robotic systems to guide a bronchoscope-a slender, flexible tube-into the lungs with greater accuracy and control compared to conventional manual methods. For instance, in March 2025, Johnson & Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received 510(k) clearance from the U.S. FDA. This system represents the next generation of the MONARCH Platform, developed to enhance lung cancer diagnosis through minimally invasive techniques. The MONARCH QUEST system integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intraprocedural 3D imaging. This integration significantly increases the precision of targeting lung nodules, particularly those located in hard-to-access regions of the lung.

In August 2024, Karl Storz SE & Co. KG, a medical technology company based in Germany, acquired Asensus Surgical Inc. for an undisclosed sum. Through this acquisition, Karl Storz intends to strengthen its position in the surgical robotics sector and broaden its offerings by incorporating Asensus Surgical's cutting-edge digital and robotic-assisted surgical technologies. Asensus Surgical Inc., headquartered in the United States, is a medical technology firm specializing in the development of surgical robots and digital solutions for a range of procedures, including lung cancer surgery.

Major players in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Inc., Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, KARL STORZ GmbH & Co. KG, Integra LifeSciences Corporation, Elekta AB, Accuray Incorporated, Richard Wolf GmbH, Angiodynamics Inc., B. Braun Melsungen AG, Quantum Surgical SAS, Sontec Instruments Inc., Novadaq Technologies Inc.

North America was the largest region in the lung cancer surgery equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lung cancer surgery equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lung cancer surgery equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lung cancer surgery equipment market consists of sales of staplers, forceps, retractors, monopolar and bipolar electrosurgical generators, ultrasonic scalpels, and pulmonary needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lung Cancer Surgery Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lung cancer surgery equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lung cancer surgery equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lung cancer surgery equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Lung Cancer Surgery Equipment Market Characteristics

3. Lung Cancer Surgery Equipment Market Trends And Strategies

4. Lung Cancer Surgery Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lung Cancer Surgery Equipment Growth Analysis And Strategic Analysis Framework

6. Lung Cancer Surgery Equipment Market Segmentation

7. Lung Cancer Surgery Equipment Market Regional And Country Analysis

8. Asia-Pacific Lung Cancer Surgery Equipment Market

9. China Lung Cancer Surgery Equipment Market

10. India Lung Cancer Surgery Equipment Market

11. Japan Lung Cancer Surgery Equipment Market

12. Australia Lung Cancer Surgery Equipment Market

13. Indonesia Lung Cancer Surgery Equipment Market

14. South Korea Lung Cancer Surgery Equipment Market

15. Western Europe Lung Cancer Surgery Equipment Market

16. UK Lung Cancer Surgery Equipment Market

17. Germany Lung Cancer Surgery Equipment Market

18. France Lung Cancer Surgery Equipment Market

19. Italy Lung Cancer Surgery Equipment Market

20. Spain Lung Cancer Surgery Equipment Market

21. Eastern Europe Lung Cancer Surgery Equipment Market

22. Russia Lung Cancer Surgery Equipment Market

23. North America Lung Cancer Surgery Equipment Market

24. USA Lung Cancer Surgery Equipment Market

25. Canada Lung Cancer Surgery Equipment Market

26. South America Lung Cancer Surgery Equipment Market

27. Brazil Lung Cancer Surgery Equipment Market

28. Middle East Lung Cancer Surgery Equipment Market

29. Africa Lung Cancer Surgery Equipment Market

30. Lung Cancer Surgery Equipment Market Competitive Landscape And Company Profiles

31. Lung Cancer Surgery Equipment Market Other Major And Innovative Companies

32. Global Lung Cancer Surgery Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lung Cancer Surgery Equipment Market

34. Recent Developments In The Lung Cancer Surgery Equipment Market

35. Lung Cancer Surgery Equipment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기